MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cncr.70493

Медицинская библиотека · Cancer · 2026

Magnetic resonance imaging-targeted biopsy with index lesion ipsilateral or bilateral systematic biopsy in prostate cancer: A multicenter, paired, noninferiority, observational trial.

Cheng Yongbing, Huang Haifeng, Wang Miao, Zhu Liangyong, Peng Shan, Li Danyan, Marra Giancarlo, Qi Ruowen, Ding Xuefei, Liu Ming, Qiu Xuefeng, Guo Hongqian

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеEquivalence TrialПеревод в очереди

Аннотация

BACKGROUND

Index lesion-focused ipsilateral systematic biopsy (iSB) has been proposed as a core-reduction alternative to MRI-targeted biopsy combined with systematic biopsy (TB + SB) for prostate cancer, but prospective multicenter validation is limited.

METHODS

This prospective multicenter trial (NCT06584279) enrolled biopsy-naive men with Prostate Imaging Reporting and Data System (PI-RADS) ≥4 lesions or PI-RADS 3 plus prostate-specific antigen (PSA) density ≥0.15 ng/mL/cm3. All underwent MRI-targeted biopsy (≥2 cores/lesion) with 12-core SB. Through core-level reclassification, the authors simulated TB + iSB (targeted biopsy combined with index lesion-ipsilateral systematic biopsy). The primary outcome was cancer detection rate (CDR) of clinically significant prostate cancer (csPCa; Grade Group ≥2) with a noninferiority margin of -3%. Secondary outcomes included clinically insignificant prostate cancer (cisPCa; Grade Group 1) detection and pathological concordance after radical prostatectomy.

RESULTS

Among 564 men (median age, 69 years; median PSA, 7.3 ng/mL), TB + iSB demonstrated a noninferior csPCa CDR versus TB + SB (40.78% vs. 42.38%; difference, -1.6 percentage points; 95% CI, -2.69 to -0.50), with the lower bound above the -3% noninferiority margin. The cisPCa CDR was slightly lower with TB + iSB than with TB + SB (13.83% vs. 14.36%; difference, -0.53 percentage points; 95% CI, -2.01 to 0.92). Among 189 surgical patients, pathological concordance was similar, whereas upgrading was numerically more frequent and downgrading numerically less frequent under simulated TB + iSB.

CONCLUSIONS

TB + iSB met the prespecified noninferiority criterion for csPCa detection relative to TB + SB and may represent a promising core-reduction strategy in transperineal MRI-guided biopsy, although the full protocol still provided additional contralateral information.

Для цитирования: Cheng Yongbing, Huang Haifeng, Wang Miao, Zhu Liangyong, Peng Shan, Li Danyan, Marra Giancarlo, Qi Ruowen, Ding Xuefei, Liu Ming, Qiu Xuefeng, Guo Hongqian. Magnetic resonance imaging-targeted biopsy with index lesion ipsilateral or bilateral systematic biopsy in prostate cancer: A multicenter, paired, noninferiority, observational trial.. Cancer. 2026. DOI: 10.1002/cncr.70493.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.